kidney - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Ardelyx reports positive data from tenapanor’s Phase III CKD trial

Tenapanor is being developed to control serum phosphorus in chronic kidney disease patients on dialysis. Credit: John Campbell.